AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
4
Halozyme Therapeutics
HALO
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -1.73%9.45B | 5.66%2.63B | -9.67%2.74B | 0.96%1.69B | -1.24%2.39B | 30.12%9.61B | 13.05%2.49B | 24.45%3.03B | 170.67%1.67B | 13.44%2.42B |
Net income from continuing operations | -2.90%8.22B | -1.13%2.02B | -2.68%2.26B | -12.47%2.02B | 7.05%1.93B | 37.11%8.47B | 7.15%2.04B | 16.93%2.32B | 94.44%2.31B | 63.17%1.8B |
Operating gains losses | 64.08%-37M | ---- | ---- | ---- | ---- | -114.05%-103M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 6.02%2.1B | 11.27%553M | 6.83%532M | 2.03%502M | 4.08%510M | 5.72%1.98B | 7.23%497M | 6.96%498M | 6.45%492M | 2.15%490M |
Deferred tax | 16.33%-574M | 73.06%-73M | 22.16%-137M | -48.68%-226M | -60.47%-138M | -98.27%-686M | -830.46%-271M | 10.34%-176M | -11.52%-152M | -70.30%-86M |
Other non cash items | 103.54%4M | -25.71%52M | 68.87%-33M | 134.78%16M | 0.00%-31M | 80.18%-113M | 108.43%70M | -132.46%-106M | -119.64%-46M | -143.06%-31M |
Change In working capital | -305.56%-438M | -65.45%76M | -82.56%79M | 32.07%-663M | -64.10%70M | 83.26%-108M | 256.70%220M | 138.05%453M | 16.46%-976M | -58.81%195M |
-Change in receivables | 106.21%10M | ---- | ---- | ---- | ---- | 39.02%-161M | ---- | ---- | ---- | ---- |
-Change in inventory | 317.65%71M | ---- | ---- | ---- | ---- | 183.33%17M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | -1,541.67%-519M | ---- | ---- | ---- | ---- | 109.30%36M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -1.72%9.45B | 5.71%2.63B | -9.67%2.74B | 0.96%1.69B | -1.24%2.39B | 30.12%9.61B | 13.05%2.49B | 24.45%3.03B | 170.67%1.67B | 13.44%2.42B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -67.90%-5.35B | 11.56%-742M | -35.69%-1.27B | -26.27%-846M | -236.44%-2.49B | -18.89%-3.18B | 21.68%-839M | -27.27%-933M | -109.90%-670M | -33.63%-741M |
Capital expenditure reported | -17.73%-2.78B | -6.61%-807M | -39.30%-794M | -19.39%-628M | -8.75%-547M | -24.12%-2.36B | -43.18%-757M | -7.30%-570M | -20.12%-526M | -25.37%-503M |
Net PPE purchase and sale | 28.42%122M | 50.00%90M | -28.57%10M | 250.00%14M | -55.56%8M | 143.59%95M | 259.28%60M | 26.13%14M | -36.51%4M | 267.35%18M |
Net business purchase and sale | -792.28%-2.2B | 313.16%81M | -398.68%-379M | -21.82%-67M | -2,276.62%-1.83B | 31.86%-246M | 90.79%-38M | 36.24%-76M | -122.80%-55M | -9.69%-77M |
Net other investing changes | 26.44%-498M | -0.95%-106M | 65.78%-103M | -77.42%-165M | 30.73%-124M | -48.14%-677M | 28.28%-105M | -220.90%-301M | 27.80%-93M | -103.41%-179M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -67.85%-5.35B | 11.67%-742M | -35.69%-1.27B | -26.27%-846M | -236.44%-2.49B | -18.93%-3.19B | 21.58%-840M | -27.27%-933M | -109.90%-670M | -33.63%-741M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -71.31%-7.49B | -220.14%-1.88B | -693.43%-1.09B | 71.91%-869M | -556.09%-3.66B | 33.53%-4.37B | 61.37%-586M | 74.93%-137M | -350.56%-3.09B | 85.43%-558M |
Net issuance payments of debt | -102.37%-71M | -110.30%-150M | -76.32%474M | 180.12%1.23B | -252.20%-1.62B | 149.83%2.99B | 9,879.45%1.46B | 67.64%2B | -215.01%-1.53B | 179.35%1.07B |
Net common stock issuance | 7.53%-2.82B | 40.89%-503M | 55.50%-469M | -63.86%-934M | -58.82%-918M | 21.61%-3.05B | -73.99%-851M | -21.26%-1.05B | 44.72%-570M | 61.63%-578M |
Cash dividends paid | -7.43%-4.87B | -4.97%-1.27B | -8.33%-1.2B | -8.12%-1.2B | -8.55%-1.21B | -8.76%-4.53B | -8.70%-1.21B | -8.90%-1.11B | -9.06%-1.11B | -8.38%-1.11B |
Proceeds from stock option exercised by employees | 26.15%328M | 53.06%75M | 112.90%132M | -70.67%22M | 33.78%99M | 4.84%260M | -38.52%49M | -0.64%62M | 58.90%75M | 26.06%74M |
Net other financing activities | -45.00%-58M | 3.03%-32M | 35.71%-27M | -70.45%13M | -20.00%-12M | -205.26%-40M | -208.41%-33M | -151.92%-42M | 324.49%44M | 20.63%-10M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -71.35%-7.5B | -220.48%-1.88B | -693.43%-1.09B | 71.91%-869M | -556.09%-3.66B | 33.53%-4.37B | 61.37%-586M | 74.93%-137M | -350.56%-3.09B | 85.43%-558M |
Net cash flow | ||||||||||
Beginning cash position | 77.21%4.58B | -65.07%1.22B | -51.29%792M | -77.40%838M | 77.21%4.58B | -45.13%2.58B | 23.61%3.5B | -13.16%1.63B | 58.75%3.71B | -45.13%2.58B |
Current changes in cash | -265.27%-3.39B | -98.87%12M | -80.45%383M | 98.80%-25M | -435.59%-3.76B | 209.73%2.05B | 375.43%1.06B | 69.70%1.96B | -438.94%-2.09B | 149.79%1.12B |
Effect of exchange rate changes | -74.14%-101M | -878.95%-148M | 151.69%46M | -362.50%-21M | 600.00%21M | 77.17%-58M | -86.64%19M | 55.19%-89M | 110.61%8M | 102.45%3M |
End cash Position | -76.30%1.09B | -76.30%1.09B | -65.07%1.22B | -51.29%792M | -77.40%838M | 77.21%4.58B | 77.21%4.58B | 23.61%3.5B | -13.16%1.63B | 58.75%3.71B |
Free cash flow | -8.04%6.67B | 5.31%1.82B | -21.02%1.94B | -7.50%1.06B | -3.86%1.84B | 32.20%7.26B | 3.53%1.73B | 29.24%2.46B | 536.51%1.15B | 10.67%1.92B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |